3 (4%) had splice site variants
A cohort of VHL patients from the Greater Toronto Area in Canada were retrospectively reviewed. Patient ID 12 had this germline mutation (c.463+2T>G) and clear cell renal cell carcinoma and pancreatic endocrine tumor. Whether patients were related, age, and sex data was not reported. ACMG PP4